Skip to content
TI11TI11TI11

Drawing based on the label description. No photo yet.

“Tofacitinib extended-release tablets 11 mg: Pink, oval, bevel edged, mat finished film-coated extended-release tablets imprinted with "TI11" on one side and plain on other side”

TI11 pill

Pill with imprint TI11 is pink, oval, 11 mm and has been identified as Tofacitinib 11 mg. It is used for rheumatoid arthritis. It is supplied by Aurobindo Pharma Limited.

Tofacitinib 11 mg

Imprint
TI11
Strength
11 mg
Used for
Rheumatoid arthritis
Color
Pink
Shape
Oval
Size
11 mm
Score
No score line
Form
Tablet, extended release
Manufacturer
Aurobindo Pharma Limited
Drug class
Cancer medicine (kinase inhibitor)
NDC
59651-685, 59651-685-30

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Tofacitinib pills and guides

What is Tofacitinib used for?

Tofacitinib is used for rheumatoid arthritis.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Rheumatoid Arthritis

Tofacitinib extended-release tablets are indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA), who have had an inadequate response or intolerance to one or more TNF blockers.

Limitations of Use

Use of tofacitinib extended-release tablets in combination with biologic disease-modifying antirheumatic drugs (DMARDs) or with potent immunosuppressants such as azathioprine and cyclosporine is not recommended.

Psoriatic Arthritis

Tofacitinib extended-release tablets are indicated for the treatment of adults with active PsA who have had an inadequate response or intolerance to one or more TNF blockers.

Limitations of Use

Use of tofacitinib extended-release tablets in combination with biologic DMARDs or with potent immunosuppressants such as azathioprine and cyclosporine is not recommended.

Ankylosing Spondylitis

Tofacitinib extended-release tablets are indicated for the treatment of adult patients with active ankylosing spondylitis (AS), who have had an inadequate response or intolerance to one or more TNF blockers.

Limitations of Use

Use of tofacitinib extended-release tablets in combination with biologic DMARDs or potent immunosuppressants such as azathioprine and cyclosporine is not recommended.

From the FDA-approved label on DailyMed (published Oct 05, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows TI11 and the other side is plain.
  • It is pink, oval, 11 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Tofacitinib Citrate

Inactive: Butylated Hydroxytoluene, Cellulose Acetate, Silicon Dioxide, Copovidone K25-31, Hydroxyethyl Cellulose (140 Mpa.s At 5%), Hydroxypropyl Cellulose (110000 Wamw), Hypromellose 2208 (4000 Mpa.s), Hypromellose 2910 (15 Mpa.s), Ferric Oxide Red, Lactose Monohydrate, Magnesium Stearate, Microcrystalline Cellulose, Polyethylene Oxide 200000, Titanium Dioxide, Triacetin, Ferrosoferric Oxide, Propylene Glycol, Shellac

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Tofacitinib pills